New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous - solution for infusion - 0.25 % - active: bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - surgical anaesthesia - epidural block for surgery. - field block (minor and major nerve blocks and infiltration).

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous; bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous - solution for injection - 0.25 % - active: bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous excipient: sodium chloride sodium hydroxide water for injection active: bupivacaine hydrochloride monohydrate 0.264% equivalent to 0.25% anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

astrazeneca limited - bupivacaine hydrochloride monohydrate 0.396% equivalent to 0.375% anhydrous - solution for injection - 0.375 % - active: bupivacaine hydrochloride monohydrate 0.396% equivalent to 0.375% anhydrous excipient: sodium chloride sodium hydroxide water for injection

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous; bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous - solution for injection - 0.5 % - active: bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous excipient: sodium chloride sodium hydroxide water for injection active: bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

astrazeneca limited - bupivacaine hydrochloride monohydrate 0.792% equivalent to 0.75% anhydrous;   - solution for injection - 0.75 % - active: bupivacaine hydrochloride monohydrate 0.792% equivalent to 0.75% anhydrous   excipient: sodium chloride sodium hydroxide water for injection

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:100000; lidocaine hydrochloride 2%;   - solution for injection - 1:100000/2% in 2.2ml - active: adrenaline acid tartrate 1:100000 lidocaine hydrochloride 2%  

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.375%;   - solution for injection - 1:200000/0.375% - active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.375%   excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 1:200000;  ; bupivacaine hydrochloride monohydrate 0.5%; adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.5% - solution for injection - 1:200000/0.5% - active: adrenaline acid tartrate 1:200000   bupivacaine hydrochloride monohydrate 0.5% excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.5% excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.75%;   - solution for injection - 1:200000/0.75% - active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.75%  

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 1:400000;  ; bupivacaine hydrochloride monohydrate 0.25%; adrenaline acid tartrate 1:400000; bupivacaine hydrochloride monohydrate 0.25% - solution for injection - 1:400000/0.25% - active: adrenaline acid tartrate 1:400000   bupivacaine hydrochloride monohydrate 0.25% excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 1:400000 bupivacaine hydrochloride monohydrate 0.25% excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration).